Autoimmune Hemolytic Anemia: Clinical Manifestations, Peripheral Blood Smear Findings, and Iron Status
Autoimmune hemolytic anemia (AIHA) does NOT cause iron deficiency; instead, it typically leads to iron overload due to chronic hemolysis releasing iron from destroyed red blood cells, and peripheral blood smear findings are characteristic and diagnostically important.
Clinical Symptoms of AIHA
The clinical presentation of AIHA is highly variable, ranging from asymptomatic compensated hemolysis to life-threatening acute anemia 1, 2, 3:
Common Presenting Features:
- Pallor (89% of cases) - the most frequent finding
- Fatigue and weakness - due to anemia
- Jaundice (43% of cases) - from elevated indirect bilirubin due to hemolysis
- Fever (38% of cases) - particularly in acute presentations
- Hepatomegaly (76%) and splenomegaly (81%) - from extramedullary hematopoiesis and RBC destruction 1
Severity Spectrum:
AIHA ranges from fully compensated (where bone marrow production matches RBC destruction) to severe, life-threatening hemolysis requiring urgent intervention 3. Approximately 50% of warm AIHA cases are primary (idiopathic), while the remainder are secondary to lymphoproliferative disorders, autoimmune diseases, infections, or drugs 3.
Peripheral Blood Smear Findings
Yes, AIHA definitively shows characteristic findings on peripheral blood smear 4, 5:
Key Smear Features:
- Spherocytes - the hallmark finding, representing RBCs that have lost membrane through partial phagocytosis
- Polychromasia - reflecting increased reticulocytes (young RBCs) from compensatory bone marrow response
- Nucleated red blood cells - may be present in severe cases
- Agglutination - particularly in cold agglutinin disease when the smear is prepared at room temperature 5
Laboratory Confirmation:
The diagnosis requires evidence of hemolysis combined with immune-mediated destruction 6, 4:
- Elevated reticulocyte count (typically 6-42%, mean 20%) 1
- Low haptoglobin - consumed by binding free hemoglobin
- Elevated lactate dehydrogenase (LDH) - released from destroyed RBCs
- Elevated indirect bilirubin - from hemoglobin breakdown
- Positive Direct Antiglobulin Test (DAT/Coombs test) - detects antibodies or complement on RBC surface 6, 4
Iron Status in AIHA: Overload, Not Deficiency
AIHA does NOT cause iron deficiency anemia; it causes the opposite problem - iron overload 7:
Why AIHA Leads to Iron Excess:
When RBCs are destroyed in AIHA, the iron contained within hemoglobin is released and recycled. Unlike iron deficiency anemia where iron stores are depleted, AIHA patients show:
- Elevated serum ferritin - significantly higher than healthy controls (p=0.008) 7
- Elevated serum hepcidin - the iron regulatory hormone increases in response to iron loading (p=0.0083 in hemolytic episodes) 7
- Increased transferrin saturation - often >50%, with one study showing mean 57.21% 7
- Normal to elevated iron stores - iron accumulates rather than depletes
Clinical Implication:
This is a critical distinction: if a patient presents with anemia and you're considering AIHA versus iron deficiency anemia, the iron studies will point in opposite directions. Low ferritin suggests iron deficiency anemia 8, while elevated ferritin with evidence of hemolysis suggests AIHA 7.
Diagnostic Algorithm
When evaluating suspected AIHA:
- Confirm hemolysis: Low hemoglobin + elevated reticulocytes + low haptoglobin + elevated LDH + elevated indirect bilirubin
- Examine peripheral smear: Look for spherocytes, polychromasia, and agglutination
- Perform DAT: Positive in most cases (IgG, C3d, or both depending on AIHA type) 4, 5
- Check iron studies: Expect elevated ferritin and transferrin saturation, NOT deficiency 7
- Identify underlying cause: Screen for lymphoproliferative disorders, autoimmune diseases, infections, or drug exposures 2, 3
Important Caveat:
Approximately 5-10% of AIHA cases may have a negative DAT despite true autoimmune hemolysis (DAT-negative AIHA), requiring more sensitive testing methods or clinical diagnosis based on response to immunosuppressive therapy 5.